Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Clinical and Genetic Study of X-Linked Juvenile Retinoschisis in the Czech Population

B. Kousal, L. Hlavata, H. Vlaskova, L. Dvorakova, M. Brichova, Z. Dubska, H. Langrova, AL. Vincent, L. Dudakova, P. Liskova

. 2021 ; 12 (11) : . [pub] 20211118

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011915

The aim of this study was to identify RS1 pathogenic variants in Czech patients with X-linked retinoschisis (XLRS) and to describe the associated phenotypes, including natural history, in some cases. Twenty-one affected males from 17 families were included. The coding region of RS1 was directly sequenced and segregation of the identified mutations was performed in available family members. In total, 12 disease-causing variants within RS1 were identified; of these c.20del, c.275G>A, c.[375_379del; 386A>T], c.539C>A and c.575_576insT were novel, all predicted to be null alleles. The c.539C>A mutation occurred de novo. Three patients (aged 8, 11 and 19 years) were misdiagnosed as having intermediate uveitis and treated with systemic steroids. Repeat spectral domain optical coherence tomography examinations in four eyes documented the transition from cystoid macular lesions to macular atrophy in the fourth decade of life. Four individuals were treated with topical dorzolamide and in two of them, complete resolution of the cystic macular lesions bilaterally was achieved, while one patient was noncompliant. Rebound phenomenon after discontinuation of dorzolamide for 7 days was documented in one case. Misdiagnosis of XLRS for uveitis is not uncommon; therefore, identification of disease-causing variants is of considerable benefit to the affected individuals.

000      
00000naa a2200000 a 4500
001      
bmc22011915
003      
CZ-PrNML
005      
20220506130841.0
007      
ta
008      
220425s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/genes12111816 $2 doi
035    __
$a (PubMed)34828422
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kousal, Bohdan $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
245    10
$a Clinical and Genetic Study of X-Linked Juvenile Retinoschisis in the Czech Population / $c B. Kousal, L. Hlavata, H. Vlaskova, L. Dvorakova, M. Brichova, Z. Dubska, H. Langrova, AL. Vincent, L. Dudakova, P. Liskova
520    9_
$a The aim of this study was to identify RS1 pathogenic variants in Czech patients with X-linked retinoschisis (XLRS) and to describe the associated phenotypes, including natural history, in some cases. Twenty-one affected males from 17 families were included. The coding region of RS1 was directly sequenced and segregation of the identified mutations was performed in available family members. In total, 12 disease-causing variants within RS1 were identified; of these c.20del, c.275G>A, c.[375_379del; 386A>T], c.539C>A and c.575_576insT were novel, all predicted to be null alleles. The c.539C>A mutation occurred de novo. Three patients (aged 8, 11 and 19 years) were misdiagnosed as having intermediate uveitis and treated with systemic steroids. Repeat spectral domain optical coherence tomography examinations in four eyes documented the transition from cystoid macular lesions to macular atrophy in the fourth decade of life. Four individuals were treated with topical dorzolamide and in two of them, complete resolution of the cystic macular lesions bilaterally was achieved, while one patient was noncompliant. Rebound phenomenon after discontinuation of dorzolamide for 7 days was documented in one case. Misdiagnosis of XLRS for uveitis is not uncommon; therefore, identification of disease-causing variants is of considerable benefit to the affected individuals.
650    _2
$a mladiství $7 D000293
650    _2
$a antihypertenziva $x aplikace a dávkování $x terapeutické užití $7 D000959
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a oční proteiny $x genetika $7 D005136
650    _2
$a frekvence genu $7 D005787
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a mutace $7 D009154
650    _2
$a rodokmen $7 D010375
650    _2
$a retinoschisis $x farmakoterapie $x genetika $x patologie $7 D041441
650    _2
$a sulfonamidy $x aplikace a dávkování $x terapeutické užití $7 D013449
650    _2
$a thiofeny $x aplikace a dávkování $x terapeutické užití $7 D013876
650    _2
$a optická koherentní tomografie $7 D041623
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hlavata, Lucia $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Vlaskova, Hana $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Dvorakova, Lenka $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Brichova, Michaela $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Dubska, Zora $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Langrova, Hana $u Department of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University and University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Vincent, Andrea L $u Department of Ophthalmology, New Zealand National Eye Centre, University of Auckland, Auckland 1142, New Zealand
700    1_
$a Dudakova, Lubica $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Liskova, Petra $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
773    0_
$w MED00174652 $t Genes $x 2073-4425 $g Roč. 12, č. 11 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34828422 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130833 $b ABA008
999    __
$a ok $b bmc $g 1789492 $s 1163116
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c 11 $e 20211118 $i 2073-4425 $m Genes $n Genes (Basel) $x MED00174652
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...